{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:49:55Z","timestamp":1788871795872,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.anl.2022.12.012","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T03:17:02Z","timestamp":1674184622000},"page":"558-564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Drug-induced olfactory and gustatory dysfunction: Analysis of FDA adverse events reporting system"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9654-7083","authenticated-orcid":false,"given":"Peter","family":"Debbaneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"McKinnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhib","family":"Haidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.anl.2022.12.012_bib0001","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11154-016-9364-1","article-title":"New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): first year results for measured olfactory dysfunction","volume":"17","author":"Hoffman","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"issue":"10","key":"10.1016\/j.anl.2022.12.012_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107541","article-title":"Olfactory dysfunction predicts 5-year mortality in older adults","volume":"9","author":"Pinto","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.anl.2022.12.012_bib0003","doi-asserted-by":"crossref","first-page":"673","DOI":"10.7326\/M18-0775","article-title":"Relationship between poor olfaction and mortality among community-dwelling older adults: a cohort study","volume":"170","author":"Liu","year":"2019","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.anl.2022.12.012_bib0004","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.mayocp.2020.05.030","article-title":"Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis","volume":"95","author":"Agyeman","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.anl.2022.12.012_bib0005","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/1073858420956905","article-title":"Anosmia in COVID-19: underlying mechanisms and assessment of an olfactory route to brain infection","volume":"27","author":"Butowt","year":"2021","journal-title":"Neuroscientist"},{"issue":"9","key":"10.1016\/j.anl.2022.12.012_bib0006","first-page":"865","article-title":"Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19-positive patients compared to subjective methods: a systematic review and meta-analysis","volume":"45","author":"Hannum","year":"2020","journal-title":"Chem Senses"},{"issue":"1","key":"10.1016\/j.anl.2022.12.012_bib0007","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamaoto.2021.3379","article-title":"Growing public health concern of COVID-19 chronic olfactory dysfunction","volume":"148","author":"Khan","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.anl.2022.12.012_bib0008","first-page":"1","article-title":"Position paper on olfactory dysfunction","volume":"56","author":"Hummel","year":"2016","journal-title":"Rhinology"},{"key":"10.1016\/j.anl.2022.12.012_bib0009","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/chemse\/27.7.623","article-title":"Biopsies of human olfactory epithelium","volume":"27","author":"Jafek","year":"2002","journal-title":"Chem Senses"},{"key":"10.1016\/j.anl.2022.12.012_bib0010","doi-asserted-by":"crossref","unstructured":"Najafloo R., Majidi J., Asghari A., Aleemardani M., Kamrava S.K., Simorgh S., Seifalian A., Bagher Z., Seifalian A.M. Mechanism of anosmia caused by symptoms of COVID-19 and emerging treatments. ACS Chem Neurosci. 202;12(20):3795-3805. PMID: 34609841.","DOI":"10.1021\/acschemneuro.1c00477"},{"issue":"9","key":"10.1016\/j.anl.2022.12.012_bib0011","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/archotol.125.9.1005","article-title":"Fluctuating olfactory sensitivity and distorted odor perception in allergic rhinitis","volume":"125","author":"Apter","year":"1999","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"5","key":"10.1016\/j.anl.2022.12.012_bib0012","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1001\/archotol.1991.01870170065015","article-title":"Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center","volume":"117","author":"Deems","year":"1991","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"11","key":"10.1016\/j.anl.2022.12.012_bib0013","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/000348940311201110","article-title":"Prevalence and causes of severe taste loss in a chemosensory clinic population","volume":"112","author":"Pribitkin","year":"2003","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"1","key":"10.1016\/j.anl.2022.12.012_bib0014","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.wjorl.2018.02.005","article-title":"Influence of medications on taste and smell","volume":"4","author":"Schiffman","year":"2018","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"issue":"5","key":"10.1016\/j.anl.2022.12.012_bib0015","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2165\/00002018-199411050-00004","article-title":"Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction","volume":"11","author":"Henkin","year":"1994","journal-title":"Drug Saf"},{"issue":"3","key":"10.1016\/j.anl.2022.12.012_bib0016","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cnur.2017.04.007","article-title":"Polypharmacy and medication management in older adults","volume":"52","author":"Kim","year":"2017","journal-title":"Nurs Clin N Am"},{"key":"10.1016\/j.anl.2022.12.012_bib0017","unstructured":"U.S. Food and Drug Administration. Warnings on three zicam intranasal zinc products. Available at: http:\/\/www.fda.gov\/ForConsumers\/ConsumerUpdates\/ucm166931.htm. Accessed March 17, 2022."},{"key":"10.1016\/j.anl.2022.12.012_bib0018","unstructured":"FDA Potential Risk Medications. Available at: https:\/\/www.fda.gov\/drugs\/questions-and-answers-fdas-adverse-event-reporting-system-faers\/july-september-2021-potential-signals-serious-risksnew-safety-information-identified-fda-adverse. Accessed March 17, 2022."},{"key":"10.1016\/j.anl.2022.12.012_bib0019","unstructured":"FDA Adverse Event Reporting System (FAERS) Public dashboard. Available at: https:\/\/www.fda.gov\/drugs\/questions-and-answers-fdas-adverse-event-reporting-system-faers\/fda-adverse-event-reporting-system-faers-public-dashboard. Accessed February 1, 2022."},{"issue":"4","key":"10.1016\/j.anl.2022.12.012_bib0020","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaad.2020.11.042","article-title":"Retrospective analysis of adverse events with dupilumab reported to the United States food and drug administration","volume":"84","author":"Wang","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.anl.2022.12.012_bib0021","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1038\/s41598-021-88958-2","article-title":"Evaluation of antibiotic-induced taste and smell disorders using the FDA adverse event reporting system database","volume":"11","author":"Kan","year":"2021","journal-title":"Sci Rep"},{"issue":"15_suppl","key":"10.1016\/j.anl.2022.12.012_bib0022","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.15_suppl.e18790","article-title":"Real-world risk of anosmia with cancer directed systemic therapy: a pharmacovigilance assessment using FDA adverse events reporting system (FAERS) database","volume":"39","author":"Kaur","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anl.2022.12.012_bib0023","unstructured":"Post T.W.. UpToDate. https:\/\/www.wolterskluwer.com\/en\/solutions\/uptodate. Accessed December 1st, 2021."},{"key":"10.1016\/j.anl.2022.12.012_bib0024","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1043-4526(02)44006-5","article-title":"Taste and smell perception in the elderly: effect of medications and disease","volume":"44","author":"Schiffman","year":"2002","journal-title":"Adv Food Nutr Res"},{"key":"10.1016\/j.anl.2022.12.012_bib0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00002018-200831030-00002","article-title":"Drug-induced taste disorders","volume":"31","author":"Doty","year":"2008","journal-title":"Drug-Saf"},{"key":"10.1016\/j.anl.2022.12.012_bib0026","series-title":"Physicians\u2019 Desk Reference","year":"2005"},{"key":"10.1016\/j.anl.2022.12.012_bib0027","unstructured":"Kane S.P. The top 300 of 2019, ClinCalc DrugStats Database, Version 2021.10. ClinCalc: https:\/\/clincalc.com\/DrugStats\/Top300Drugs.aspx. Updated September 15, 2021. Accessed February 9, 2022"},{"issue":"6","key":"10.1016\/j.anl.2022.12.012_bib0028","first-page":"499","article-title":"Drug-related dysgeusia: a systematic review","volume":"16","author":"Mortazavi","year":"2018","journal-title":"Oral Health Prev Dent"},{"key":"10.1016\/j.anl.2022.12.012_bib0029","first-page":"68","article-title":"Taste and smell alterations in cancer patients\u2014real problems with few solutions","volume":"7","author":"Halyard","year":"2009","journal-title":"J Support Oncol"},{"key":"10.1016\/j.anl.2022.12.012_bib0030","first-page":"58","article-title":"Taste and odor abnormalities in cancer patients","volume":"7","author":"Hong","year":"2009","journal-title":"J Support Oncol"},{"issue":"10","key":"10.1016\/j.anl.2022.12.012_bib0031","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJMoa1402551","article-title":"Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma","volume":"371","author":"Benboubker","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2022.12.012_bib0032","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJMoa1805104","article-title":"Rituximab plus lenalidomide in advanced untreated follicular lymphoma","volume":"379","author":"Morschhauser","year":"2018","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.anl.2022.12.012_bib0033","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.19.00010","article-title":"AUGMENT: a phase III study of lenalidomide plus rituximab versus placebo plus rituximab in relapsed or refractory indolent lymphoma","volume":"37","author":"Leonard","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anl.2022.12.012_bib0034","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejca.2018.12.006","article-title":"The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: a phase 2 clinical trial","volume":"108","author":"Bjarnason","year":"2019","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.anl.2022.12.012_bib0035","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-001079","article-title":"Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial","volume":"5","author":"Albiges","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.anl.2022.12.012_bib0036","unstructured":"Celgene Corporation. Revlimid (lenalidomide) [package insert]. U.S. Food and Drug Administration website. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/021880Orig1s064lblrpl.pdf. Revised August 2021. Accessed March 18, 2022."},{"key":"10.1016\/j.anl.2022.12.012_bib0037","unstructured":"Pfizer Incorporated. Sutent (sunitinib) [package insert]. U.S. Food and Drug Adminstration website. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/021938s037lbl.pdf. Revised August 2020. Accessed March 18, 2022."},{"key":"10.1016\/j.anl.2022.12.012_bib0038","unstructured":"Timeline of progress of immunotherapy drugs. https:\/\/www.cancerresearch.org\/en-us\/immunotherapy\/timeline-of-progress. Accessed March 17, 2022."},{"issue":"10","key":"10.1016\/j.anl.2022.12.012_bib0039","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2165\/11593120-000000000-00000","article-title":"Drug-induced taste and smell alterations: a case\/non-case evaluation of an italian database of spontaneous adverse drug reaction reporting","volume":"34","author":"Tuccori","year":"2011","journal-title":"Drug Saf"},{"key":"10.1016\/j.anl.2022.12.012_bib0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5414\/CPP47096","article-title":"A PK\/PD approach on the effects of clarithromycin against oral and nasal microbiota of healthy volunteers","volume":"47","author":"Del Bortolo Ruenis","year":"2009","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.anl.2022.12.012_bib0041","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.mlg.0000191549.17796.13","article-title":"Intranasal zinc and anosmia: the zinc-induced anosmia syndrome","volume":"116","author":"Alexander","year":"2006","journal-title":"Laryngoscope"},{"issue":"7","key":"10.1016\/j.anl.2022.12.012_bib0042","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archoto.2010.111","article-title":"The Bradford Hill criteria and zinc-induced anosmia: a causality analysis","volume":"136","author":"Davidson","year":"2010","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2022.12.012_bib0043","unstructured":"Sales of the leading nasal spray\/drops\/inhaler brands in the United States in 2019 (in million U.S. dollars). https:\/\/www.statista.com\/statistics\/433651\/leading-nasal-spray-brands-in-the-us. Accessed November 18, 2022."},{"issue":"6","key":"10.1016\/j.anl.2022.12.012_bib0044","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jpainsymman.2011.11.011","article-title":"Coming to your senses: detecting taste and smell alterations in chemotherapy patients. A systematic review","volume":"44","author":"Gamper","year":"2012","journal-title":"J Pain Symptom Manag"},{"issue":"2","key":"10.1016\/j.anl.2022.12.012_bib0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/15360288.2012.676618","article-title":"A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders","volume":"26","author":"Lyckholm","year":"2012","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"1\u20134","key":"10.1016\/j.anl.2022.12.012_bib0046","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/biof.5520120111","article-title":"Zinc deficiency and taste dysfunction; contribution of carbonic anhydrase, a zinc-metalloenzyme, to normal taste sensation","volume":"12","author":"Komai","year":"2000","journal-title":"Biofactors"},{"key":"10.1016\/j.anl.2022.12.012_bib0047","first-page":"1","article-title":"Proposed mechanism for anosmia during COVID-19: the role of local zinc distribution","volume":"7","author":"Equils","year":"2020","journal-title":"J Trans Sci"},{"issue":"1","key":"10.1016\/j.anl.2022.12.012_bib0048","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/lio2.513","article-title":"Intra-nasal zinc level relationship to COVID-19 anosmia and type 1 interferon response: a proposal","volume":"6","author":"Equils","year":"2020","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"3","key":"10.1016\/j.anl.2022.12.012_bib0049","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/10408398.2010.527023","article-title":"Zinc deficiency and taste perception in the elderly","volume":"53","author":"Aliani","year":"2013","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"8","key":"10.1016\/j.anl.2022.12.012_bib0050","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/lary.26558","article-title":"Smoking and olfactory dysfunction: a systematic literature review and meta-analysis","volume":"127","author":"Ajmani","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2022.12.012_bib0051","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1749-6632.2009.03924.x","article-title":"Effects of aging on the human taste system","volume":"1170","author":"Schiffman","year":"2009","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.anl.2022.12.012_bib0052","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3389\/fphar.2020.00326","article-title":"An increasing trend in the prevalence of polypharmacy in Sweden: a nationwide register-based study","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.anl.2022.12.012_bib0053","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1080\/14740338.2018.1546841","article-title":"An update on the clinical consequences of polypharmacy in older adults: a narrative review","volume":"17","author":"Wastesson","year":"2018","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"10.1016\/j.anl.2022.12.012_bib0054","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/lary.28692","article-title":"Anosmia and Ageusia: common findings in COVID-19 patients","volume":"130","author":"Vaira","year":"2020","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2022.12.012_bib0055","unstructured":"John T.J., Wear W.E.S., Seshadri M.S. https:\/\/www.worldometers.info\/coronavirus\/ Accessed March 17 2022."},{"issue":"1","key":"10.1016\/j.anl.2022.12.012_bib0056","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0194599820926473","article-title":"The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis","volume":"163","author":"Tong","year":"2020","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2022.12.012_bib0057","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/0194599820922992","article-title":"COVID-19 anosmia reporting tool: initial findings","volume":"163","author":"Kaye","year":"2020","journal-title":"Otolaryngol.\u2013Head Neck Surg"},{"issue":"2","key":"10.1016\/j.anl.2022.12.012_bib0058","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaip.2020.09.021","article-title":"Emerging causes of drug-induced anaphylaxis: a review of anaphylaxis-associated reports in the FDA adverse event reporting system (FAERS)","volume":"9","author":"Yu","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anl.2022.12.012_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.107832","article-title":"Drug-induced liver injury associated with antiseizure medications from the FDA adverse event reporting system (FAERS)","volume":"117","author":"Kamitaki","year":"2021","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.anl.2022.12.012_bib0060","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3390\/cancers12040826","article-title":"Cardiovascular toxicity of tyrosine kinase inhibitors used in chronic myeloid leukemia: an analysis of the FDA adverse event reporting system database (FAERS)","volume":"12","author":"Cirmi","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.anl.2022.12.012_bib0061","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00439-2019","article-title":"The effect of gefapixant, a P2\u00a0\u00d7\u00a03 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study","volume":"54","author":"Morice","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anl.2022.12.012_bib0062","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/00001756-199904060-00037","article-title":"Localization of ATP-gated P2\u00a0\u00d7\u00a02 and P2\u00a0\u00d7\u00a03 receptor immunoreactive nerves in rat taste buds","volume":"10","author":"Bo","year":"1999","journal-title":"Neuroreport"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814622002401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814622002401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:40:52Z","timestamp":1759952452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814622002401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0385814622002401"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2022.12.012","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced olfactory and gustatory dysfunction: Analysis of FDA adverse events reporting system","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2022.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}